Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224941, what the precise recommendation made by the Clinical Reference Group referred to in that Answer was; whether that recommendation related to (a) in year or (b) ongoing routine commissioning; and if he will make a statement.
NHS England has advised that its Neuroscience Clinical Reference Group’s recommendation was to approve the clinical policy to support the routine commissioning of levodopa-carpidopa intestinal gel for advanced Parkinson’s disease and to go out to full public consultation.
The recommendation related to an in year commissioning decision.